Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction
暂无分享,去创建一个
K. Lackner | C. Hamm | C. Liebetrau | L. Gaede | H. Möllmann | A. Rolf | C. Troidl | H. Nef | O. Dörr | T. Keller | Astrid Hahnel | Jedrzej Hoffmann
[1] C. Hamm,et al. Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[2] C. Hamm,et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. , 2013, Journal of the American College of Cardiology.
[3] C. Hamm,et al. Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. , 2013, Clinical chemistry.
[4] C. Hamm,et al. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. , 2012, Clinical chemistry.
[5] D. Dixon,et al. Economic Evaluation of a Heart-Type Fatty Acid Binding Protein Based Protocol for Rapid Chest Pain Assessment , 2012 .
[6] Mary Jo Kurth,et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. , 2012, The American journal of emergency medicine.
[7] S. Blankenberg,et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.
[8] Asif Ahmed,et al. Heparin Elevates Circulating Soluble fms-Like Tyrosine Kinase-1 Immunoreactivity in Pregnant Women Receiving Anticoagulation Therapy , 2011, Circulation.
[9] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[10] C. Mueller,et al. Heparin Strongly Induces Soluble Fms-Like Tyrosine Kinase 1 Release In Vivo and In Vitro—Brief Report , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[11] A. Jaffe,et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. , 2011, Journal of the American College of Cardiology.
[12] C. Hamm,et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. , 2011, American heart journal.
[13] Lin Lin,et al. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. , 2011, International journal of cardiology.
[14] M. Becker,et al. Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome , 2011, Clinical Research in Cardiology.
[15] R. Twerenbold,et al. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. , 2011, European heart journal.
[16] R. Karas,et al. Elevated Soluble fms-Like Tyrosine Kinase-1 Levels in Acute Coronary Occlusion , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[17] W. Gibler,et al. Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department , 2011, Current cardiology reviews.
[18] I. Mikaelian,et al. Time Course Characterization of Serum Cardiac Troponins, Heart Fatty Acid–binding Protein, and Morphologic Findings With Isoproterenol-induced Myocardial Injury in the Rat , 2010, Toxicologic pathology.
[19] H. Katus,et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.
[20] E. Vicaut,et al. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. , 2010, American heart journal.
[21] C. Heeschen,et al. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome , 2010, Heart.
[22] S. Kristensen,et al. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. , 2010, The American journal of emergency medicine.
[23] N. Morgenthaler,et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. , 2009, Journal of the American College of Cardiology.
[24] D. Atsma,et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. , 2008, Experimental and molecular pathology.
[25] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[26] Lars Edenbrandt,et al. Direct hospital costs of chest pain patients attending the emergency department: a retrospective study , 2006, BMC emergency medicine.
[27] Barry J Maron,et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.
[28] H. Smithline,et al. Can CK-MB and cTn-I be detected in the peripheral circulation within the first 10 min of acute coronary ischemia? , 2003, Medical hypotheses.
[29] K. Matre,et al. Release of cardiac troponin I after temporally graded acute coronary ischaemia with electrocardiographic ST depression. , 2002, International journal of cardiology.
[30] Jeroen J. Bax,et al. [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. , 2016, Giornale italiano di cardiologia.
[31] Michael Marber,et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction , 2010 .
[32] I. Menown,et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. , 2009, The American journal of cardiology.